T24 In Vivo Tumorigenesis Assay

This assay is to provide T24-based In Vivo Tumorigenesis Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.

T24

Human

The T24 cell line was established from a transitional cell carcinoma of the bladder in a female patient in 1973. Reports in the literature indicated a wide range of tumorigenicity for T24 when injected subcutaneously in immunocompromised murine hosts.

Bladder Cancer

Oncology

In Vivo Tumorigenesis Assay

T24-cell based In Vivo Tumorigenesis Assay

Tumorigenicity is defined the property of a cell to form tumors when inoculated into an immunosuppressed animal model. Generally, test cells and tumor cells as positive control are administered subcutaneously into immunosuppressed nude mice. The number of animals developing tumors are compared with a positive control reference cell line.

Oncology In Vivo Assays